Your search did not match any results.
We suggest you try the following to help find what you're looking for:
New Delhi, India—28 September, 2018
In order to fight the growing problem of counterfeit drugs in India, NITI Aayog, Government of India’s premier policy institute, has teamed with global cloud leader Oracle, India’s premier super specialty hospital Apollo Hospitals, and global pharmaceutical manufacturer Strides Pharma Sciences, to pilot a real drug supply chain using blockchain decentralized ledger and IoT software.
Oracle’s blockchain software permanently registers a drug’s record in the manufacturer’s drug supply chain (serial number, labelling, scanning), leaving no scope for record tampering. From here on, at every point of hand change, it records the drug’s movement – from manufacturer to logistics, from stockist to hospital, or from pharmacy to consumer. In case of a fake drug, the software will detect irregularity and notify the concerned nodal point. Additionally, Oracle IoT provides functionality to track critical information such as chemical ingredients of the drug or maintenance of temperature control in case of life saving drugs or vaccines.
The Indian pharmaceutical industry is the third largest in the world in volume, accounting for 10 percent of the world’s production. The issue of fake and counterfeit drugs is a global problem, impacting citizens around the world, including in India.
Together, NITI Aayog, Oracle, Apollo Hospitals and Strides Pharma aim to bring transparency, accountability and efficiency in tracing and tracking drugs manufactured in India.
The major advantages of blockchain software will be its ability to allow the sharing of information across the supply chain securely recording every exchange of information, and the tamper-proof nature of records of drug movement, which would ensure there is no dispute if an offender is identified.
Amitabh Kant, CEO, NITI Aayog, says “This agreement with Oracle and our partnership with Apollo Hospitals and Strides Pharma, will help ensure that Indian drug manufacturers and healthcare experts have access to a standards-based, modern technology platform – blockchain and IoT, to help eliminate fake drug distribution.”
Shailender Kumar, Regional Managing Director, Oracle India, says, “With blockchain, every movement of the drug through its supply chain is recorded – that way, the drug supply chain is completely transparent, secure, decentralized and verifiable. We believe blockchain and IoT can play a significant role in ceasing fake drug distribution and we are all geared to work with NITI Aayog in this major program.”
The National Institution for Transforming India, also called NITI Aayog, was formed via a resolution of the Union Cabinet on January 1, 2015. NITI Aayog is the premier policy ‘Think Tank’ of the Government of India, providing both directional and policy inputs. While designing strategic and long term policies and programmes for the Government of India, NITI Aayog also provides relevant technical advice to the Centre and States.
The Oracle Cloud offers complete SaaS application suites for ERP, HCM and CX, plus best-in-class database Platform as a Service (PaaS) and Infrastructure as a Service (IaaS) from data centers throughout the Americas, Europe and Asia. For more information about Oracle (NYSE:ORCL), please visit us at oracle.com/in/
Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country.
Apollo has emerged as Asia's foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies, Primary Care & Diagnostic Clinics. The Group also has Telemedicine units across 10 countries, Health Insurance Services, Global Projects Consultancy, Medical Colleges, Medvarsity for E-Learning, Colleges of Nursing and Hospital Management and a Research Foundation.
Strides Pharma Science Limited is a global pharmaceutical company engaged in the development, manufacture and marketing of a wide range of IP-led niche and technically complex pharmaceutical products for regulated and emerging markets.
Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.